Skip to content
NeuroTechGuide

FDA grants Breakthrough designation to Nia's AI-guided implant for memory loss

The Smart Neurostimulation System targets memory problems after traumatic brain injury, stimulating only when encoding is likely to fail.

In briefRegulationImplants

Nia Therapeutics has received FDA Breakthrough Device designation for its Smart Neurostimulation System, a wireless implant for episodic memory loss in adults with a history of moderate-to-severe traumatic brain injury. It records from 60 channels in four brain regions and uses machine-learning models trained on each patient’s signals to stimulate at moments when memory encoding is likely to fail. In earlier studies of neurosurgical patients, the approach was linked to a 19% improvement in recall.

It is the first Breakthrough designation for TBI-related memory loss. The company plans clinical trials starting in 2027.

Learn more: Closed-loop systems · Nia Therapeutics

Share:XLinkedInBlueskyEmail

More news